Hanneke van Laarhoven

The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis

ter Veer, E., Haj Mohammad, N., van Valkenhoef, G., Ngai, L. L., Mali, R. M. A., Anderegg, M. C., van Oijen, M. G. H. & van Laarhoven, H. W. M., 2016, In: Journal of the National Cancer Institute. 108, 10, p. djw166

Research output: Contribution to journal › Review article › Academic › peer-review

Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition

Ebbing, E. A., Steins, A., Fessler, E., Stathi, P., Lesterhuis, W. J., Krishnadath, K. K., Vermeulen, L., Medema, J. P., Bijlsma, M. F. & van Laarhoven, H. W. M., 2017, In: Gastroenterology. 153, 1, p. 63-76.e14

Research output: Contribution to journal › Article › Academic › peer-review

Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease

ter Veer, E., van Rijssen, L. B., Besselink, M. G., Mali, R. M. A., Berlin, J. D., Boeck, S., Bonnetain, F., Chau, I., Conroy, T., van Cutsem, E., Deplanque, G., Friess, H., Glimelius, B., Goldstein, D., Herrmann, R., Labianca, R., van Laethem, J-L., Macarulla, T., van der Meer, J. H. M., Neoptolemos, J. P., & 13 othersOkusaka, T., O'Reilly, E. M., Pelzer, U., Philip, P. A., van der Poel, M. J., Reni, M., Scheithauer, W., Siveke, J. T., Verslype, C., Busch, O. R., Wilmink, J. W., van Oijen, M. G. H. & van Laarhoven, H. W. M., 2018, In: lancet oncology. 19, 3, p. e151-e160

Research output: Contribution to journal › Review article › Academic › peer-review

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Dutch Pancreatic Cancer Group, 1 Dec 2023, In: BMC Cancer. 23, 1, 70.

Research output: Contribution to journal › Erratum/Corrigendum › Academic

Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) (Trials, (2022), 23, 1, (913), 10.1186/s13063-022-06829-1)

Dutch Pancreatic Cancer Group, 1 Dec 2023, In: Trials. 24, 1, 55.

Research output: Contribution to journal › Erratum/Corrigendum › Academic › peer-review

SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy

Kuijper, S. C., Pape, M., Haj Mohammad, N., van Voorthuizen, T., Verhoeven, R. H. A. & van Laarhoven, H. W. M., 15 Mar 2023, In: International journal of cancer. 152, 6, p. 1202-1209 8 p.

Research output: Contribution to journal › Article › Academic › peer-review